The contract covers drug discovery research using iPS cells and this vector, which was developed by DNAVEC and allows to induce the differentiation of target cells for the study of various diseases.
DNAVec news release, Oct. 23, 2014
DNAVEC signs research agreement with CiRA, Kyoto University, on Sendai virus vector